NEWSMAX @NEWSMAX
The U.S. health regulator on Wednesday approved Switzerland-based Ferring Pharmaceuticals' fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States. https://t.co/fHrEEsynoU — PolitiTweet.org